Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Aurinia Pharmaceuticals Ownership Summary


Aurinia Pharmaceuticals is owned by 8.92% institutional investors, 7.44% insiders, and 83.64% retail investors. Tang capital management is the largest institutional shareholder, holding 9.10% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.15% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAurinia Pharmaceuticals8.92%7.44%83.64%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryBiotech Stocks 34.84%11.71%53.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management12.23M9.10%$181.24M
Blackrock9.27M6.44%$52.94M
Blackrock funding, inc. /de7.85M5.84%$116.27M
Nea management company3.97M2.95%$58.83M
Two sigma investments, lp3.43M2.55%$50.81M
Arrowstreet capital, limited partnership3.28M2.44%$48.67M
State street2.53M1.88%$37.45M
Morgan stanley2.23M1.66%$33.09M
Marshall wace, llp1.87M1.40%$27.78M
Renaissance1.66M1.24%$24.66M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management12.23M9.20%$181.24M
Nea management company3.97M3.34%$58.83M
Ironwood investment management113.07K0.70%$1.68M
Rice hall james & associates487.90K0.40%$7.23M
Andina capital management26.85K0.35%$397.93K
Hussman strategic advisors84.00K0.27%$1.24M
Pdt partners265.49K0.23%$3.93M
Virtus investment advisers53.27K0.22%$789.42K
Highmark wealth management35.20K0.21%$521.60K
Virtus fund advisers7.03K0.20%$63.15K

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp3.43M0.04%1.47M
Tang capital management12.23M9.20%900.00K
Blackrock9.27M0.00%609.18K
Aqr capital management948.81K0.01%467.47K
Goldman sachs group1.43M0.00%427.18K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.63M
Rock springs capital management lp---1.18M
Point72 asset management---849.62K
Readystate asset management lp---657.84K
Millennium management117.17K0.00%-621.14K

New Positions

HolderShares% AssetsChangeValue
Healthcare of ontario pension plan trust fund275.30K0.01%275.30K$4.08M
Hood river capital management269.31K0.04%269.31K$2.98M
Hillsdale investment management209.90K0.08%209.90K$3.11M
Stifel financial165.40K0.00%165.40K$2.45M
Cookson peirce122.48K0.08%122.48K$1.82M

Sold Out

HolderChange
Clearstead advisors-2.00
Vima-25.00
Nelson, van denburg & campbell wealth management group-26.00
Federation des caisses desjardins du quebec-40.00
Stephens consulting-45.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026136-50.00%11,979,121-83.37%80.32%68-49.25%32-61.90%
Dec 31, 2025193-23.41%37,728,298-42.57%271.23%98-9.26%56-38.46%
Sep 30, 2025206-10.04%43,375,015-25.50%311.78%86-14.00%7720.31%
Jun 30, 20252271.79%58,203,989-6.12%412.10%99-1.98%646.67%
Mar 31, 20253-98.60%312,556-99.46%-0.01%1-99.00%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF2.81M2.15%23.69K
Fidelity Small Cap Index1.17M0.90%12.84K
iShares Russell 2000 Growth ETF978.01K0.75%2.52K
iShares Biotechnology ETF869.39K0.66%13.23K
State St Russell Sm/Mid Cp® Indx NL Cl C820.80K0.60%-
Russell 2000 Equity Index Fund B750.38K0.56%-195.00
State St Russell Sm/Mid Cp® Indx SL Cl I722.20K0.55%11.70K
Vanguard Russell 2000 ETF587.66K0.44%-3.71K
Lazard US Sm Cap Eq WW Dist EUR577.32K0.43%58.09K
Janus Henderson Small/Md Cp Gr Alpha ETF539.37K0.42%18.39K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 02, 2026TANG KEVIN-Buy$1.20M
Feb 27, 2026TANG KEVIN-Buy$23.01K
Mar 03, 2026TANG KEVIN-Buy$2.62M
Mar 02, 2026TANG KEVIN-Buy$1.65M
Feb 27, 2026TANG KEVIN-Buy$3.03M

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q16-
2025 Q4--
2025 Q331
2025 Q2--

AUPH Ownership FAQ


Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 8.92%, followed by 7.44% insiders and 83.64% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 34.84%, which Aurinia Pharmaceuticals falls below.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Tang capital management (12.23M shares, 9.10%), Blackrock (9.27M shares, 6.44%), and Blackrock funding, inc. /de (7.85M shares, 5.84%). Together, they hold 21.38% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 9.20% of its assets in 12.23M Aurinia Pharmaceuticals shares, valued at 181.24M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.15% of its total shares outstanding invested in 2.81M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools